Specify a stock or a cryptocurrency in the search bar to get a summary
Ignyte Acquisition Corp
PKBOPeak Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing therapeutics for the treatment of patients with cancer, inflammatory, and rare diseases in the United States. The company's lead product candidate is PHP-303, which is in Phase 2 clinical study for the treatment of alpha-1 antitrypsin deficiency and acute respiratory distress syndrome. It also develops Trop2 PH1, an antibody-drug-conjugate in preclinical trials for solid tumors. Peak Bio, Inc. is based in Pleasanton, California. Address: 4900 Hopyard Road, Pleasanton, CA, United States, 94588
Analytics
WallStreet Target Price
15 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures PKBO
Dividend Analytics PKBO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History PKBO
Stock Valuation PKBO
Financials PKBO
Results | 2019 | Dynamics |